Yusha Liu, MD
Plastic and Reconstructive Surgery · Seattle, WANPI 1063866069
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $14,081 with a category attached, or 71.0%. Arthrex accounts for 71.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $10,874 and has fallen 90.3% since, to $1,056 in 2025.
Across 23 payments — averaging $612.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$10K
- Checkpoint Surgical, Inc$3K
- Acumed LLC$541
- Trimed, Inc.$350
- Axogen$341
- Globus Medical$97
- plus $32 from 1 others
What the payments were for
- Grants$10,00071%
- Travel & lodging$2,28016%
- Food & beverage$1,80113%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $10,000 |
| Checkpoint Surgical, Inc | 13 | $2,721 |
| Acumed LLC | 4 | $541 |
| Trimed, Inc. | 1 | $350 |
| Axogen | 2 | $341 |
| Globus Medical | 1 | $97 |
| Evolution Surgical, Inc | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Checkpoint Stimulators$2,533
- ACUMED$1,114
- AVANCE NERVE GRAFT$341
- OsteoMed$173
How this compares
$14,081 in reported general payments places this provider in the 85th percentile of 63 plastic and reconstructive surgery providers in Washington.
See all plastic and reconstructive surgery providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in Seattle
- Srinivas SusarlaSeattle$32K
- Javad SajanSeattle$21K
- Joseph GrussSeattle$15K
- Hakim SaidSeattle$6K
- Joshua CooperSeattle$6K
- Erin AnstadtSeattle$6K
- Otway LouieSeattle$5K
- Emily ZurbuchenSeattle$4K
- Grace UmSeattle$3K
- Jourdan GottliebSeattle$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.